Error: Could not add to watchlist. X
+ Watchlist

Northwest Biotherapeutics Inc

NBYB:GR
Frankfurt
0.54
EUR
0.01
1.13%
As of 1:29 PM EST 12/9/2016
Open
0.51
Day Range
0.48 - 0.54
Volume
2,300
Previous Close
0.53
52Wk Range
0.10 - 4.23
1 Yr Return
-85.15%
Open
0.51
Day Range
0.48 - 0.54
Volume
2,300
Previous Close
0.53
52Wk Range
0.10 - 4.23
1 Yr Return
-85.15%
YTD Return
-82.34%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
66.944
Shares Outstanding (m)
124.662
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+1.23%
% Price Change
+1.47%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.
Address
4800 Montgomery Lane
Suite 800
Bethesda, MD 20814
United States
Phone
1-240-497-9024
Show More